Probability of AML evolution for patients with MDS according to cytopenia lines and WT1/PRAME transcript levels. (A) Probability of AML evolution for all patients with MDS based on cytopenia lines. (B) Probability of AML evolution for patients with MDS based on WT1 transcript levels. (C) Probability of AML evolution for patients with MDS based on PRAME transcript levels.